ArticleJournal of virology2025

Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants.

Ashley C Beavis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.